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probability of transition to healthy, overweight or obese states
or to die from CVD, cancer or other causes. Model inputs
were population and death records from Turkish Statistical
Institute, overweight and obesity prevalence from Turkish
National Chronic Disease Survey, 2011, daily mean SSB intake
from Turkish National Diet and Nutrition Survey. We used
DISMOD II software to estimate the incidence of overweight
and obesity. The effect of tax was calculated using price elas-
ticities obtained from previous published studies. We compared
three scenarios: The baseline scenario involved no change in
consumption of SSBs. In two additional scenarios, we mod-
elled the effect of a 10% and 20% tax on decreasing SSBs
intake. We then modelled the effect of this SSB decrease on
BMI and obesity prevalence on the Turkish population. We
further calculated the population attributable risk fraction of
obesity to estimate the CVD and cancer cases potentially pre-
ventable. We also conducted a probabilistic sensitivity analysis
to estimate 95% uncertainty intervals (95% UI).
Results We forecast that in this closed cohort, by the year
2031, approximately 4,201,100 (4,130,000–4,270,000) men
and 5,419,000 (5,305,000–5,537,000) women would be obese.
However implementing a 10% SSB tax could result in approx-
imately 21,900 (19,800–29,040) fewer obese men and 13,500
(12,900–15,400) fewer obese women. A 20% tax might result
in 41,900 (40,100–48,100) fewer obese men and 24,800
(15,600–28,700) fewer obese women. Overall, a 20% tax
could result in a 0.7% reduction in obesity prevalence in the
whole cohort. This might result in approximately 29,700
fewer CVD cases and 13,400 fewer obesity related cancer
cases by 2031.
Conclusion A tax on Sugar Sweetened Beverages in the Turk-
ish population could usefully reduce the prevalence of obesity,
cardiovascular disease and common cancers. These findings
reinforce the growing evidence of health benefits with SSB
taxation policies in diverse countries.
OP75 SUGAR SWEETENED BEVERAGES COVERAGE IN THE
BRITISH MEDIA – AN ANALYSIS OF PUBLIC HEALTH
ADVOCACY VERSUS PRO-INDUSTRY MESSAGING
A Elliott-Green, L Hyseni, F Lloyd-Williams*, H Bromley, S Capewell. Public Health and
Policy, University of Liverpool, Liverpool, UK
10.1136/jech-2016-208064.75
Background Sugar–sweetened beverages (SSBs) are an increas-
ing contributor to rising rates of diabetes, obesity and cardio-
vascular disease. The media has an important role in framing
perceptions of these products and therefore has significant
potential to influence public health policy. We assessed the
extent of media-based public health advocacy versus pro-indus-
try messaging regarding SSBs.
Methods We conducted a systematic analysis to identify and
examine all articles regarding SSBs published in mainstream
British print newspapers and their online news websites from
1st January 2014 to 1st January 2015. We initially conducted
a brief literature search to develop appropriate search terms
and categorisations for grouping and analysing the articles.
Articles were then coded according to the publishing newspa-
per, article type, topic, prominence and slant (pro- or anti-
SSB). A contextual analysis was undertaken to examine key
messages in the articles.
Results 1295 full-text articles published during 2014 were
assessed for eligibility of which 374 were included in this
analysis. The majority of articles (81%) suggested that SSBs
are unhealthy. Messaging from experts, campaign groups and
health organisations was fairly consistent about the detrimental
effects of SSB on health. SSBs were associated with a large
variety of topics and sub-topics, most frequently health effects,
followed by regulation and product consumption. Of those
articles discussing the health impact of SSBs, the most promi-
nent subtopic was youth’s consumption of SSBs.
However, relatively few articles assessed any approaches or
solutions to potentially combat the problems associated with
SSBs. Only a quarter (24%) suggested any policy change. 31%
placed the responsibility for combating consumption of sugar
on individuals and 36% offered no solutions, merely highlight-
ing the problems associated with SSBs over-consumption.
Meanwhile, articles concerning the food industry produced
consistent messages emphasising consumer choice and individ-
ual responsibility for making choices regarding SSB consump-
tion, and promoting and advertising their products. The food
industry thus often managed to avoid association with the
negative press that their products were receiving.
Conclusion Sugar–sweetened beverages featured heavily in
mainstream British print newspapers and their online news
websites during 2014. Public health media advocacy was
prominent throughout, with a growing consensus that sugary
drinks are bad for people’s health. However, the challenge for
public health will be to mobilise supportive public opinion to
help implement effective regulatory policies. Only then will
our population’s excess consumption of sugar sweetened bev-
erages come under control.
OP76 CORPORATE FUNDING OF SCIENTIFIC RESEARCH: A
CASE STUDY OF COCA-COLA
1P Matos Serodio*, 1D Stuckler, 2M Mckee, 3D Cohen. 1Department of Sociology,
University of Oxford, Oxford, UK; 2Department of Health Services Research and Policy,
London School of Hygiene and Tropical Medicine, London, UK; 3Associate Editor, British
Medical Journal, London, UK
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Background Global corporations have come under sustained
attack in recent years for their lack of transparency. In partic-
ular, concerns have been raised about their funding of
research to support their advocacy campaigns, in some cases
with concealment of the links between the funder and the
researcher. Most attention has been focused on the tobacco
industry, which has a long history of conducting research
designed to create confusion and to reframe the agenda in
ways that advance its interests. Similarly, the food industry has
sought to reframe the debate on obesity as one driven primar-
ily by too little physical activity rather than by high levels of
intake of energy dense food. In this paper we report the find-
ings of the case study of Coca-Cola. The Coca-Cola Corpora-
tion has been the subject of extensive criticism, in particular
because of its support of academics at certain American uni-
versities who have been in the forefront of advancing the
argument that the obesity epidemic should be tackled through
greater physical activity rather than reductions in energy dense
products. However, it has also claimed that it embraced trans-
parency by publishing a list of researchers that it funds,
although this was in response to widespread public criticism
when it was realised that Coca-Cola had donated more than
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$4 million to the non-profit group “Global Energy Balance
Network”, whose research framed obesity as determined by
the lack of physical activity rather than by dietary habits.
However, we challenge Coca-Cola’s commitment to transpar-
ency by demonstrating that its list of scientific experts that it
collaborated with is selective and severely incomplete.
Methods Using web scraping tools, we have collected informa-
tion from the Web of Science Core Collection on every article
published in a scientific journal that acknowledges the Coca-
Cola Company or the Coca-Cola Foundation as a funding
agency. From a total sample of 262 articles, involving approxi-
mately 2,100 authors, we impose further restrictions to the
sampling procedure and end up with a total of 247 articles
and 647 authors.
Results 151 articles, published in roughly 100 different jour-
nals, and involving 468 authors, were funded by grants from
the Coca-Cola Company or the Coca-Cola Foundation (its
philanthropic arm), but were not listed on Coca-Cola’s press
release of scientific experts it has funded since 2010.
Discussion Many of these articles equate the obesity epidemic
with lack of physical activity, which raises important questions
about the role of industry funding in academic research.
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OP77 COMMISSIONING SERVICES FOR DISEASE PREVENTION
IN ENGLAND: A QUALITATIVE EXAMINATION OF
BARRIERS AND ENABLERS
1K Mackenzie*, 1E Goyder, 1M Johnson, 1A Lee, 1S Salway, 1J Horsley, 2A Vedio. 1School
of Health and Related Research, University of Sheffield, Sheffield, UK; 2Infectious Diseases,
Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK
10.1136/jech-2016-208064.77
Background Part of the rationale for transferring public health
responsibilities from the NHS to local government in 2013,
was that it would give renewed focus to “upstream” preven-
tive interventions, to improve population health and tackle
inequalities more effectively. However there is a risk of poten-
tial unintended consequences in terms of the impact on com-
missioning preventive services at the interface between local
government and the NHS. Such services may be difficult to
prioritise, particularly given the greater visibility and demand
for services for treatment of symptomatic conditions. To date,
the actual impact of current commissioning arrangements on
preventive service commissioning remains unclear.
The aim of this work was therefore to identify common
themes relating to the current barriers and enablers of com-
missioning prevention services.
Methods Information from interviews and workshops with
commissioners and providers were synthesised from two inde-
pendent projects: a research project exploring barriers to
effective management of the Hepatitis B risk in the Chinese
community (CATH-B) and a consultation conducted for Public
Health England to inform the roll-out of the national Diabetes
Prevention Programme (DPP). Data was collected from 23
interviews (3 for DPP; 20 for CATH-B) and 4 workshops (2
for DPP; 2 for CATH-B) for thematic analysis. Findings were
discussed with stakeholders to ensure appropriate interpreta-
tion and contextualisation.
Results Common barriers that emerged from both commis-
sioner and provider perspectives included: lack of clarity
regarding commissioning responsibilities; other competing pri-
orities in the context of finite budgets; lack of understanding
of the evidence base; lack of perception that prevention was a
priority for services driven by increasing urgent demands; the
long-term nature of outcomes for preventive services.
Potential enablers included making the service a higher pri-
ority for commissioners by linking it to national targets and
funding and the availability of local community providers with
capacity to deliver appropriate services. However, the “top-
down” nature, and complexities, of commissioning meant
using local community-based providers was not always
feasible.
Conclusion Since the transfer of responsibility for public
health and in a context of shrinking resources, prevention
services have been put at risk by lack of clarity about where
responsibilities lie, lack of local champions for prevention
services in many areas, and complexities of commissioning
locally tailored, appropriate and accessible services.
Fragmentation and complexity of commissioning responsibil-
ities and lack of clarity about budgets are widely seen as sig-
nificant barriers to effective commissioning suggesting
integrated budgets “place-based” commissioning will be essen-
tial to facilitate effective service commissioning and delivery.
OP78 IMPROVING TRIAL RECRUITMENT THROUGH IMPROVED
COMMUNICATION ABOUT PATIENT AND PUBLIC
INVOLVEMENT: AN EMBEDDED CLUSTER RANDOMISED
RECRUITMENT TRIAL
1,2A Hughes-Morley*, 3M Hann, 4C Frasier, 4K Lovell, 5O Meade, 6B Young, 7C Roberts,
4L Cree, 4D More, 1P Bower. 1MRC North West Hub for Trials Methodology Research,
University of Manchester, Manchester, UK; 2York Trials Unit, University of York, York, UK;
3NIHR School for Primary Care Research, University of Manchester, Manchester, UK; 4School
of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK; 5School
of Health Sciences, The University of Nottingham, Nottingham, UK; 6MRC North West Hub
for Trials Methodology Research, University of Liverpool, Liverpool, UK; 7Department of
Biostatistics, University of Manchester, Manchester, UK
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Background Evidence is emerging that patient and public
involvement in research (PPIR) may improve recruitment into
randomised controlled trials, but the best methods to achieve
improvement are unclear. Although many trials use PPIR to
improve design and conduct, many do not communicate their
use of PPIR clearly to potential participants. Directly commu-
nicating PPIR might encourage participation through increased
patient confidence and trust in a trial. We aimed to develop
and evaluate the impact on recruitment an intervention com-
municating PPIR in a trial to potential participants.
Methods This study was embedded in EQUIP, a cluster rando-
mised controlled trial which allocated mental health teams in
England to either a training intervention group to improve
service user and carer involvement in care planning, or to a
control group (no training).
We conducted a cluster randomised trial of a recruitment
intervention communicating PPIR, embedded within the
EQUIP trial. The principles underlying the intervention were
informed by a systematic review and a workshop that
included mental health service users and trialists.
Working with EQUIP PPIR partners (service users and
carers) we developed the intervention using a leaflet to adver-
tise the nature and function of the PPIR. Professional graphic
design optimised readability and impact. Patients identified as
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potentially eligible for EQUIP were randomised to receive the
leaflet or not, alongside the standard trial information. The
primary outcome was the proportion of participants enrolled
in EQUIP. The secondary outcome was the proportion
expressing interest in taking part.
Results 34 clusters (mental health teams) were recruited, and
8182 potential participants were randomised. Preliminary anal-
yses show that for the primary outcome, 4% of patients
receiving the PPIR leaflet were enrolled vs. 5.3% in the con-
trol group. For the secondary outcome 7.3% of potential par-
ticipants receiving the PPIR leaflet responded positively to the
invitation to participate, vs. 7.9% in the control group. Future
analyses will be by intention-to-treat and use logistic regression
to estimate between-group odds ratios (ORs) and correspond-
ing 95% confidence intervals. A planned secondary analysis
will explore whether the impact of the intervention is moder-
ated by age and gender.
Conclusion In preliminary analysis of this large trial, commu-
nicating PPIR demonstrated no benefits for improving the
numbers of potential participants expressing interest in the
trial, and reduced trial enrolment. Our findings contrast with
the literature suggesting PPIR benefits recruitment. We will
discuss the potential reasons for this finding, along with impli-
cations for future recruitment practice and research.
OP79 ASSESSING THE IMPACT OF FLORIDA’S ‘STAND YOUR
GROUND’ LAW ON PATTERNS OF HOMICIDE: AN
INTERRUPTED TIME SERIES STUDY
1,2DK Humphreys*, 3A Gasparrini, 4DJ Wiebe. 1Department of Social Policy and
Intervention, University of Oxford, Oxford, UK; 2Green Templeton College, University of
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Background Homicide rates in the United States are unusually
high for a developed country. Despite a gradual reduction in
homicide rates over the last 100 years, homicide is still one
of the leading causes of pre-mature death in U.S. citizens
below the age of 40. There is continual debate about the con-
sequences of stricter gun control measures, but less discussion
about other kinds of legislative changes that may affect rates
of homicide adversely. Since 2005, 22 U.S. states have
amended their self-defence laws, removing the “duty to
retreat” principle. “Stand your ground” (SYG) laws, specifi-
cally, give individuals legal immunity for use of lethal force in
any situation in which individuals perceive a threat. Critics of
this legislation are concerned that weakening the punitive con-
sequences of using lethal force may serve to escalate aggressive
and violent encounters, with significant implications for public
health. This study examines the impact of the first SYG law
on homicide rates in Florida.
Methods An interrupted time series analysis was performed
using state-level rates of homicide between 1999 and 2014.
Seasonally adjusted segmented Poisson regression models were
used to assess whether the onset of the SYG law was associ-
ated with a deviation from the underlying trend. Stratified
analyses were conducted to examine whether effects differed
by ethnicity, age, and sex. To assess the impact of simultane-
ous cyclical factors, we have used non-equivalent control vari-
ables: alternative outcome variables that are sensitive to
similar changes in cyclical factors, but not hypothesised to be
influenced by the intervention under examination.
Results The mean monthly homicide rate prior to the change
in legislation was 0.49 deaths per 100,000, with an underlying
trend of 0.1% decrease per month. We found an abrupt
increase in monthly homicide rates of 24.7% associated with
the onset of Florida’s SYG law (RR 1.25; 95% CI: 1.17–1.33,
CI: £ 0.001). Stratified analysis found increases in homicide
across all demographic groups, with notable increases in Cau-
casian populations and in those aged 20–34 years.
Conclusion The removal of a “duty to retreat” in Florida has
been associated with a substantial increase in the homicide
rates. If the reported association is causal, we estimate that
the implementation of Florida’s SYG law produced an addi-
tional 20 homicides per month, or a further 2,229 homicides
since the law came into effect. This suggests that the change
in the law may have served to escalate the severity of harm
incurred from violent altercations.
OP80 FORMATIVE EVALUATION OF THE UK NHS DIABETES
PREVENTION PROGRAMME DEMONSTRATOR PHASE:
REVIEW OF BASELINE INFORMATION
1,2AM Rodrigues*, 1,2A Sherrington, 1,2L Penn, 1,2R Bell, 2,3CD Summerbell, 4M White,
1,2AJ Adamson, 1,2FF Sniehotta. 1Institute of Health and Society, Newcastle University,
Newcastle-upon-Tyne, UK; 2Fuse: the Centre for Translational Research in Public Health, UK;
3School of Medicine, Pharmacy and Health, Durham University, Stockton on Tees, UK;
4CEDAR: Centre for Diet and Activity Research, Cambridge University, Cambridge, UK
10.1136/jech-2016-208064.80
Background The NHS diabetes prevention programme (NHS
DPP) aims to identify people at high-risk of developing Type
2 diabetes, and offer them an intensive lifestyle change inter-
vention (ILCI). The development, evaluation and implementa-
tion of the NHS DPP is planned in phases, starting with
formative evaluation of a demonstrator phase. This study aims
to 1) review and appraise activities related to recruitment,
intervention delivery and equality across the seven NHS DPP
demonstrator sites; and 2) inform the further development
and ability to evaluate the programme.
Methods Information from documentation supplied by demon-
strator sites was extracted and mapped against recommenda-
tions contained in NICE guidance PH38 (prevention of
diabetes), NHS DPP specification and equality indicators. To
facilitate the mapping exercise, themes within the guidance
documents were identified and used in a coding framework to
characterise demonstrator site programmes. Mapping was con-
ducted by three reviewers and discrepancies were resolved
through discussion.
Results Elements identified were categorised within four
themes: (a) raising awareness and recruitment; (b) intervention
components, design and delivery; (c) inequalities and adapta-
tion and; (d) quality assurance, monitoring and training.
Responsibilities for awareness raising and enrolment in the
ILCI were unclear. In all sites referral to ILCI was via primary
care or NHS Health Checks. Where a blood test was reported
HbA1c was the most usual measure. Intervention content
reporting was insufficiently detailed and varied across sites.
The proposed programmes were less intensive and shorter
than recommended. Place of residence and gender impacted
on ILCI delivery in terms of choice of venue and availability
of single-sex groups. Recommended minimum data items to
evaluate programmes (age, sex, ethnicity, postcode, height,
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weight, HbA1c and physical activity levels) were specified by
five sites, whereas dietary data were only specified by one
site. Programme deliverers included a range of professionals.
The training received varied across sites, with regular review
of intervention delivery, the deliverer and their training needs
in some sites.
Conclusion This review developed a useful framework to
reflect on the different elements, actors and responsibilities
needed to implement an evaluable NHS DPP. Information pro-
vided at baseline from some sites, had items missing from
intervention content, equality indicators and quality assurance
procedures. Findings were used to make recommendations for
the subsequent stages of the NHS DPP implementation and
evaluation. Lack of clarity and detail in intervention specifica-
tion will jeopardise evaluability of the NHS DPP.
CVD
OP81 EXPLAINING THE FALL IN CORONARY MORTALITY IN
JAPAN BETWEEN 1980 AND 2012: IMPACT MODELLING
ANALYSIS
1M O’Flaherty, 2F Nakamura*, 2K Nishimura, 1M Guzman-Castillo, 3A Sekikawa,
1S Capewell, 2Y Miyamoto, 3L Kuller. 1Department of Public Health and Policy, University of
Liverpool, Liverpool, UK; 2Department of Statistics and Data Analysis, Centre for Cerebral
and Cardiovascular Disease Information, National Cerebral and Cardiovascular Centre, Suita,
Japan; 3Pitt of Public Health, University of Pittsburgh, Pittsburgh, USA
10.1136/jech-2016-208064.81
Background Coronary heart disease (CHD) mortality has
declined substantially in Japan for several decades. However,
the contributory factors remain unclear because major CHD
risk factor levels have paradoxically increased since 1980,
notably cholesterol, obesity and diabetes. Our objective is to
quantify the contributions of prevention and treatment to the
coronary heart disease mortality trends in Japan between 1980
and 2012.
Methods We used the previously validated IMPACT model to
analyse mortality trends between 1980 and 2012 in the Japa-
nese population aged 35–84 years. This model integrates data
on changes in population size, CHD mortality, risk factors,
and uptake of evidence-based cardiac treatments. Main data
sources included official vital statistics, national patient, health
and nutrition surveys, and the health insurance claims data.
Relative risks and regression coefficients came from the pub-
lished meta-analyses. The difference between observed and
expected CHD deaths in 2012 was then partitioned among
treatment benefits and risk factor changes. We also performed
probabilistic sensitivity analyses to quantify the potential
effects of parameter uncertainty.
Results From 1980 to 2012, age-adjusted CHD mortality rates
in Japan fell by 61%, resulting in 75,680 fewer CHD deaths
in 2012 than if rates had not fallen. Improvements in medical
and surgical treatments were associated with approximately
59% (range, 56% to 61%) of the total mortality decrease.
Major contributions came from therapy for angina in the
community (explaining approximately 17% of the mortality
fall), antihypertensive medication (»10%), and heart failure
therapies (»7%).
Risk factor changes accounted for approximately 31%
(19% to 42%) of the mortality fall. Some 24% from decreases
in systolic blood pressure and 11% from falls in smoking
prevalence. However, rises in cholesterol, BMI and diabetes
negated some of these benefits, potentially increasing mortality
by 2%, 3% and 6% respectively.
Conclusion Approximately 60% of the CHD mortality fall in
Japan between 1980 and 2012 was attributable to increases in
evidence-based medical treatments, and 30% to falls in popu-
lation risk factors. However, the substantial contributions from
falls in blood pressure and smoking were offset by adverse
trends in cholesterol, obesity and diabetes. Our results high-
light the potential for further improvements in cardiovascular
risk factors in Japan.
OP82 LONG-LIVED PARENTS AND CARDIOVASCULAR
OUTCOMES: 8 YEAR FOLLOW-UP IN 189,000 UK
BIOBANK PARTICIPANTS
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Ageing, University of Connecticut, Connecticut, USA; 8National Institute on Ageing, National
Institutes of Health, Baltimore, USA
10.1136/jech-2016-208064.82
Background Coronary heart disease (CHD) risk, and especially
the risk of early onset myocardial infarction, shows a strong
familial pattern. Associations with other circulatory conditions
and overall survival are less well studied. We estimated the
associations between age at death of the parents and the risk
of 18 prevalent and incident conditions, and mortality, in a
large middle-aged UK cohort.
Methods Prospective data from the UK Biobank was available
for 189,076 participants aged 55–73 years (including 696 off-
spring of centenarians). Participants were followed-up from
baseline for hospital admissions and mortality (mean period of
6 years and 5.5 years respectively, maximum >8 years for
both). We excluded premature parental deaths and parental
survival was ranked into short, intermediate and long-lived
categories. A combined ranked parental longevity score was
created, with a higher score indicating a greater parental age
at death. Cox proportional hazards regression models investi-
gated the associations of parental longevity score and the risk
of prevalent and incident disease and mortality.
Results At baseline, increasing parents’ age at death was associ-
ated with participants being more physically active and having
more education and higher income, plus having less obesity
and lower rates of smoking. Adjusting for age, sex, ethnicity,
education, income, smoking status, alcohol intake, physical
activity and body mass index, parental longevity was associ-
ated with lower prevalence and incidence of several common
circulatory conditions, including peripheral vascular disease
(per longevity category Hazard Ratio for incidence: 0.73;
95% CI: 0.64, 0.83), stroke (HR, 0.77; 95% CI: 0.70, 0.86),
heart failure (HR, 0.78; 95% CI: 0.70, 0.87), coronary heart
disease (HR, 0.86; 95% CI: 0.81, 0.91) and atrial fibrillation
(HR, 0.88; 95% CI: 0.82, 0.94). Offspring of longer-lived
parents also had a lower risk of all-cause mortality (HR, 0.87;
95% CI: 0.84, 0.91) and a markedly lower risk of CHD mor-
tality (HR, 0.74; 95% CI: 0.65, 0.83). However, the
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